Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer’s continuum when only subtle changes in Aβ pathology are detectedMarc Suárez‐Calvet, Natàlia Vilor‐Tejedor, Eider M. Arenaza‐Urquijo et al.|EMBO Molecular Medicine|2020Cited by 411
Plasma p-tau231 and p-tau217 as state markers of amyloid-β pathology in preclinical Alzheimer’s diseaseMarta Milà‐Alomà, Kaj Blennow, Nicholas J. Ashton et al.|Nature Medicine|2022Cited by 349
Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer's <i>continuum</i>Marta Milà‐Alomà, Gemma Salvadó, Juan Domingo Gispert et al.|Alzheimer s & Dementia|2020Cited by 260
Association between insomnia and cognitive performance, gray matter volume, and white matter microstructure in cognitively unimpaired adultsJosé Luís Molinuevo, Oriol Grau‐Rivera, Grégory Operto et al.|Alzheimer s Research & Therapy|2020Cited by 113
Associations between air pollution and biomarkers of Alzheimer’s disease in cognitively unimpaired individualsSilvia Alemany, José Luís Molinuevo, Marta Crous‐Bou et al.|Environment International|2021Cited by 99